Skip to main content
    C

    Caris Life Sciences, Inc. Common Stock (CAI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $19.94
    -1.06 (-5.05%)

    Market Cap: $6.02B

    Last updated: Nov 17, 2026 at 4:35 PM ET

    Caris Life Sciences, Inc. Common Stock (CAI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Caris Life Sciences, Inc. Common Stock (CAI) has a market cap of $6.02B. It earned $96.06M on revenue of $1.05B over the last 12 months.

    Total Valuation

    Market Cap$6.02B
    Latest price (Nov 17, 2026)$19.94

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.36% in the quarter ended Sep 30, 2026.

    Shares Outstanding283.89M
    Shares Change (YoY)+0.64%
    Shares Change (QoQ)+0.36%

    Valuation Ratios

    Sales and book value multiples are 5.4x and 8.9x.

    Forward P/E165.7x
    P/S Ratio5.4x
    Forward P/S5.8x
    P/B Ratio8.9x
    P/TBV Ratio9.1x
    P/FCF Ratio195.8x
    P/OCF Ratio71.8x

    Valuation history and multiples

    Price Statistics

    The stock is down 16.39% over 52 weeks and trades 31.74% below its 50-day average.

    Beta (1Y)2.01
    52-Week Change-16.39%
    1-Month Change-35.07%
    3-Month Change-12.39%
    6-Month Change+33.29%
    Total Return (1Y)-16.39%
    Return vs SPY (1Y)-27.64%
    Max Drawdown (1Y)-49.58%
    Sharpe Ratio (1Y)-0.25
    Correlation with SPY (1Y)0.39
    50-Day Average$29.21
    200-Day Average$21.60
    52-Week Range$14.19 to $36.50
    RSI (14 Days)25.4
    Average Volume (20 Days)4.10M

    Financial Position

    Current assets cover 6.71x current liabilities, and total debt is 0.61x shareholder equity.

    Current Ratio6.71x
    Quick Ratio5.84x
    Debt / Equity0.61x
    Debt / FCF13.60x

    Returns and Efficiency

    Return on Capital Employed (ROCE)10.96%
    Asset Turnover0.94x
    Inventory Turnover2.47x
    Receivables Turnover8.38x
    Cash Conversion Cycle107 days

    Taxes

    Income tax took 1.55% of pretax income over the last 12 months.

    Income Tax (TTM)$1.51M
    Effective Tax Rate1.55%

    Scores

    CAI has a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $1.05B over the last 12 months.

    Revenue$1.05B
    Gross Profit$724.14M
    Operating Income$139.94M
    Pretax Income$97.57M
    Net Income$96.06M
    EBITDA$145.96M
    EBIT$120.23M
    Reported EPS (TTM)-$0.21

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 50.75% of the $1.26B in total assets.

    Total Debt$393.27M
    Working Capital$908.32M
    Shareholder Equity$639.48M
    Book Value Per Share$2.25
    Tangible Book Value$620.14M
    Tangible Book Per Share$2.18
    Total Assets$1.26B
    Total Liabilities$616.14M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $54.98M of capital spending, operating cash flow left $28.91M of free cash flow.

    Operating Cash Flow$83.89M
    Capital Expenditures$54.98M
    Free Cash Flow$28.91M
    FCF Per Share$0.10
    Depreciation and Amortization$26.34M
    Share Repurchases$31.46M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 13.35%.

    Gross Margin69.09%
    Operating Margin13.35%
    Pretax Margin9.31%
    Net Margin9.16%
    EBITDA Margin13.93%
    EBIT Margin11.47%
    FCF Margin2.76%

    Dividends and Yields

    CAI does not pay a dividend. Its free cash flow yield is 0.51%.

    FCF Yield0.51%
    Buyback Yield0.56%
    Shareholder Yield0.56%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CAI

    What is CAI's market cap?

    Caris Life Sciences, Inc. Common Stock has a market cap of $6.02B.

    How many shares of CAI are outstanding?

    Caris Life Sciences, Inc. Common Stock has 283.89M shares outstanding. The count is up 0.64% from a year earlier.

    Does CAI pay a dividend?

    No. Caris Life Sciences, Inc. Common Stock does not pay a dividend.